These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17112774)

  • 21. Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines.
    Wagenblast J; Hambek M; Baghi M; Knecht R
    Anticancer Res; 2008; 28(2A):687-92. PubMed ID: 18507008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of 8p23 deletions with poor survival in head and neck cancer.
    Bockmühl U; Ishwad CS; Ferrell RE; Gollin SM
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):451-5. PubMed ID: 11283506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
    Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
    Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.
    Brandt B; Meyer-Staeckling S; Schmidt H; Agelopoulos K; Buerger H
    Clin Cancer Res; 2006 Dec; 12(24):7252-60. PubMed ID: 17189396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population.
    Csejtei A; Tibold A; Koltai K; Varga Z; Szanyi I; Gobel G; Prantner I; Steffler D; Feher G; De Blasio A; Ember I; Kiss I
    Anticancer Res; 2009 Oct; 29(10):4169-73. PubMed ID: 19846968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases.
    Salzman R; Kanková K; Pácal L; Tomandl J; Horáková Z; Kostrica R
    Neoplasma; 2007; 54(4):321-5. PubMed ID: 17822322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
    Thomas SM; Bhola NE; Zhang Q; Contrucci SC; Wentzel AL; Freilino ML; Gooding WE; Siegfried JM; Chan DC; Grandis JR
    Cancer Res; 2006 Dec; 66(24):11831-9. PubMed ID: 17178880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer.
    Geurts TW; Balm AJ; van Velthuysen ML; van Tinteren H; Burgers JA; van Zandwijk N; Klomp HM
    Head Neck; 2009 Feb; 31(2):220-6. PubMed ID: 18972427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.
    da Costa Andrade VC; Parise O; Hors CP; de Melo Martins PC; Silva AP; Garicochea B
    Exp Mol Pathol; 2007 Feb; 82(1):53-7. PubMed ID: 17084840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can patients with head and neck cancers invading carotid artery gain survival benefit from surgery?
    Roh JL; Kim MR; Choi SH; Lee JH; Cho KJ; Nam SY; Kim SY
    Acta Otolaryngol; 2008; 128(12):1370-4. PubMed ID: 18607928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
    Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming Growth Factor-alpha reduces carcinogen-induced DNA damage in mini-organ cultures from head-and-neck cancer patients.
    Baumeister P; Schwenk-Zieger S; Reiter M; Welz C; Harréus U
    Mutat Res; 2009; 677(1-2):42-5. PubMed ID: 19539778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
    Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.